PTEN-C1ORF226 Fusion FISH Probe
The PTEN-C1ORF226 Fusion FISH Probe is used to confirm a fusion of the PTEN and C1ORF226 genes. The fusion of the PTEN and C1ORF226 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PTEN-C1ORF226-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PTEN-C1ORF226-20-AQAQ | 20 (40 μL) | 200 μL |
|
PTEN Gene Summary
This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
Gene Name: Phosphatase And Tensin Homolog
Chromosome: CHR10: 89623194 -89728532
Locus: 10q23.31
C1orf226 Gene Summary
The Chromosome 1 Open Reading Frame 226 (C1orf226) gene is located on chr1 :162351519-162356608 at 1q23.3.
Gene Name: Chromosome 1 Open Reading Frame 226
Chromosome: CHR1: 162351519 -162356608
Locus: 1q23.3
Gene Diseases
The PTEN C1ORF226 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|